The PD-1/PD-L1 or PD-L2 signalling pathway is a negative regulatory mechanism that inhibits T cell proliferation and cytokine production.
PD-1 [CD279]/PD-L1 [CD274] Pathway
![PD-1 [CD279]/PD-L1 [CD274] Pathway PD-1 [CD279]/PD-L1 [CD274] Pathway](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/pd-1-600x400px-600x300.png)
![PD-1 [CD279]/PD-L1 [CD274] Pathway PD-1 [CD279]/PD-L1 [CD274] Pathway](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/pd-1-600x400px-600x300.png)
The PD-1/PD-L1 or PD-L2 signalling pathway is a negative regulatory mechanism that inhibits T cell proliferation and cytokine production.

AdipoGen Life Sciences specialises in the development of recombinant proteins that show enhanced activity and stability, produced in mammalian cells.

List of AdipoGen Life Sciences’ neutralising antibody detection kits for SARS-CoV-2 variants

List of AdipoGen Life Sciences’ validated recombinant proteins for ACE2 & COVID-19 research

List of AdipoGen Life Sciences’ SARS-CoV-2 recombinant antibodies

Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite and autism.

The plant Euphorbia resinifera contains the most potent irritant known so far. It was isolated and identified as resiniferatoxin (RTX).

Manumycin A is an inhibitor of exosome biogenesis & secretion. Targeting exosome biogenesis could exert RAS signalling inhibitors’ anticancer effects.

Using nanoparticle technology in making vaccines for infectious diseases/cancer is advancing & enhances the immunogenicity of some vaccine candidates.

LEADGENE® Indoxyl Sulfate ELISA Kit is the first CE-registered antibody-based assay tool for chronic kidney disease (CKD) on the global market.